Federal contractor · PARAMUS, NJ

OCTAPHARMA USA INC.

OCTAPHARMA USA INC. received $3.7M in federal contract obligations in FY2026, on 2 awards (−32% vs FY2025). Since FY2025: $9.2M. Its largest customer was Defense Health Agency ($3.7M).

Obligations · FY2026
$3.7M
New awards
2
Sole-source
100%
Single offer
0.0%
UEI
FKJKNJVR1HV4
Other than small businessForeign-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 5.5MFY2025
  2. 3.7MFY2026

Top buying agencies

Obligations in FY2026.

  1. Defense Health Agency$3.7M100%
    2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$3.7M100%

Where the work was performed

  1. Bergen County, NJ$1.9M52%
  2. Frederick County, MD$1.8M48%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $3.7M
  • Sole-source awards100%
    US 30% · $3.7M
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

  1. Defense Health Agency$3.7M
    Department of Defense · 2 awards

Largest awards

  1. 1,600 UNITS OF OCTAPLASLG DELIVERED TO BLOOD BANK WEST$1.9M
    Defense Health Agency· Bergen County, NJ· Health & medical· Jan 15, 2026 – Jan 15, 2026· HT942726FE009
  2. PURCHASE OF 1,500 OCTAPLASLG UNITS FOR THE UNITED STATES MARINE CORP$1.8M
    Defense Health Agency· Frederick County, MD· Health & medical· Mar 4, 2026 – Mar 4, 2026· HT942726FE025

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH$2.5M+17% in FY2026
    SEOUL, KOR · 23% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturing
  2. PHADIA US INC$2M+32% in FY2026
    PORTAGE, MI · 18% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturing
  3. MEDPHARM INC.$2.5M−28% in FY2026
    DEDEDO, GU · 17% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

  • Octapharma USA, Inc.AI match · 100%
Lobbying · 2026
$180K
2 reports
Lobbying · 2025–2026
$320K

Lobbying by year

  1. 2025$140K
    2 reports
  2. 2026$180K
    2 reports

Top issues

  1. Manufacturing4 reports
  2. Medical and disease research, clinical labs4 reports
  3. Trade (domestic and foreign)4 reports

Who was contacted

  1. Defense - Dept of (DOD)4 reports
  2. U.S. SENATE4 reports
  3. Executive Office of the President (EOP)2 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

  1. Cornerstone Government Affairs, Inc.$320K
    4 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.